Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T14:10:49.820Z.
Calculation as of: 2026-10-06T14:10:49.820Z.
Quote observation: 2026-10-06T14:10:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f6ebf84f3f464cb4543e326b3b96959337d3a5891063dc6ef63f2f1a4491a7a3
PEG RATIO
N/A
Artelo Biosciences, Inc.
Market Cap
$1.38M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | $1.38M | N/A |
| PMGC Holdings Inc. (ELAB)vs › | $1.43M | N/A |
| Genprex, Inc. (GNPX)vs › | $1.33M | N/A |
| Curis, Inc. (CRIS)vs › | $1.46M | N/A |
| INVO Fertility, Inc. (IVF)vs › | $1.47M | N/A |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.48M | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.20M | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.18M | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.10M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
